A newly filed Periodic Transaction Report shows Hon. Gilbert Cisneros, a member of the U.S. House of Representatives, purchased shares of Marvell Technology, Inc. (MRVL) on July 17, 2026. The transaction was made by Cisneros personally and is valued in the disclosed range of $1,001 to $15,000, a bracket the STOCK Act uses for reporting purposes rather than an exact dollar figure.
The filing lists the holding as being maintained through 150 Main Street Trust, with Bank of America named as the custodial brokerage. Our internal classification tags this filing as a ‘congress buy’ signal, meaning a sitting lawmaker added to a position in a publicly traded company rather than trimming or exiting one.
An Insider Sale in the Same Window
What makes this filing notable is the timing relative to activity elsewhere at Marvell Technology. Company insider Koopmans Chris sold MRVL shares on August 3, 2026, in a transaction valued at $1,805,000. That sale landed within 30 days of Cisneros’s purchase, placing a congressional buy and a substantial insider sale of the same stock inside a single monthly window.
STOCK Act disclosures and insider Form 4 filings are separate reporting regimes with different thresholds and different reasons for triggering a filing, so this overlap is not, by itself, evidence of coordination or wrongdoing. Lawmakers and corporate insiders operate under different rules, different information sets, and often different time horizons. Still, when a member of Congress buys into a name that a company insider is simultaneously selling out of in size, it is the kind of juxtaposition that readers tracking both congressional and insider activity tend to want flagged.
Marvell Technology has drawn attention from a range of institutional and political filers in recent periods, and readers following broader portfolio-level activity around similar names may also want to see how larger asset managers have positioned themselves. For context on how one such manager has adjusted its holdings over recent quarters, see our coverage of Manufacturers Life Insurance Company’s tracked 13F moves.
No additional details beyond the transaction date, amount range, and brokerage arrangement were included in the filing. As with all Periodic Transaction Reports, the disclosure satisfies the member’s legal reporting obligation under the STOCK Act and does not itself indicate any nonpublic information was involved.